Page 21 - Bio Developments News Today

TrakCel is a provider of integrated cellular orchestration solutions for the management, control and tracking of cell and gene therapy products.

TrakCel is a provider of integrated cellular orchestration solutions for the management, control and tracking of cell and gene therapy products.

Moderna has revealed that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for Spikevax, its updated COVID-19 vaccine.

LabGenius, a company focused on machine learning (ML) for antibody discovery, has presented key data in a poster presentation at the Single-Domain Antibodies 2023 Meeting.

Global biopharmaceutical company Takeda is working to modernize its operations in order to better serve clinical trial sites, patients and sponsor outcomes.

Celltrion Healthcare has launched a new campaign to celebrate a decade of biosimilar innovation in Europe.

Vaxess Technologies, a life sciences company developing a shelf-stable vaccine patch with potential for self-application, has announced an additional $9 million in venture capital funding, with investors including RA Capital, The Engine, and GHIC, and Ulu Ventures.

Mission Bio, a leader in single-cell multi-omic solutions for precision medicine, has launched its new Tapestri Genome Editing Solution.

Kuano, a drug discovery company combining quantum mechanics with AI, has announced the close of its £1.8 million seed funding round, led by Mercia Ventures, and including ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory LLP, and other Angel investors.

Arrowhead Pharmaceuticals has spotlighted the potential of RNA interference (RNAi) therapeutic candidates in the lungs, with a clinical late breaker and multiple pre-clinical presentations at this year’s European Respiratory Society (ERS) International Congress 2023 in Milan, Italy.